_id
690f377cccc777a4e85d17ea
Ticker
BOLD
Name
Boundless Bio, Inc. Common Stock
Exchange
NASDAQ
Address
10955 Alexandria Way, San Diego, CA, United States, 92121
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://boundlessbio.com
Description
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA). The company's lead product candidate is BBI-355, an ecDNA-directed therapeutic candidate and oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. It also develops BBI-098, a picomolar biochemical inhibition of checkpoint kinase 1 demonstrating central nervous system penetrance in preclinical models. In addition, the company offers ECHO, an ecDNA harboring oncogenes diagnostic test to detect ecDNA in patient tumor specimens; and Spyglass platform, a platform used to identify druggable targets in oncogene amplified cancers. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Last Close
1.23
Volume
423620
Current Price
1.285
Change
0.045
Last Updated
2026-01-20T16:51:36.264Z
Image
-
Ipo Date
2024-03-28T00:00:00.000Z
Market Cap
27758160
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9893
Sentiment Sources
3
Rating
3.3333
Target Price
3
Strong Buy
0
Buy
1
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
310000
Gross Profit
-310000
Operating Expenses
14838000
Operating Income
-15148000
Interest Expense
-
Pretax Income
-13879000
Net Income
-13879000
Eps
-0.6199857053515591
Dividends Per Share
-
Shares Outstanding
22385611
Income Tax Expense
-
EBITDA
-13569000
Operating Margin
-
Total Other Income Expense Net
1269000
Cash
14980000
Short Term Investments
102590000
Receivables
-
Inventories
-
Total Current Assets
120156000
Property Plant Equipment
47979000
Total Assets
168721000
Payables
1136000
Short Term Debt
3052000
Long Term Debt
-
Total Liabilities
58552000
Equity
110169000
Bs_currency_symbol
USD
Depreciation
310000
Change In Working Capital
1847000
Cash From Operations
-10195000
Capital Expenditures
15000
Cash From Investing
10478000
Cash From Financing
0
Net Change In Cash
283000
Cf_currency_symbol
USD
PE
-
PB
0.2611080249434959
ROE
-12.597917744556092
ROA
-8.226006246999484
FCF
-10210000
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
6
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
7.5
Quality Investing Score
2
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
310000
Quarters > 0 > income Statement > gross Profit
-310000
Quarters > 0 > income Statement > operating Expenses
14838000
Quarters > 0 > income Statement > operating Income
-15148000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-13879000
Quarters > 0 > income Statement > net Income
-13879000
Quarters > 0 > income Statement > eps
-0.6199857053515591
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
22386000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-13569000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1269000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
14980000
Quarters > 0 > balance Sheet > short Term Investments
102590000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
120156000
Quarters > 0 > balance Sheet > property Plant Equipment
47979000
Quarters > 0 > balance Sheet > total Assets
168721000
Quarters > 0 > balance Sheet > payables
1136000
Quarters > 0 > balance Sheet > short Term Debt
3052000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
58552000
Quarters > 0 > balance Sheet > equity
110169000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-13879000
Quarters > 0 > cash Flow > depreciation
310000
Quarters > 0 > cash Flow > change In Working Capital
1847000
Quarters > 0 > cash Flow > cash From Operations
-10195000
Quarters > 0 > cash Flow > capital Expenditures
15000
Quarters > 0 > cash Flow > cash From Investing
10478000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
283000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.6199857053515591
Quarters > 0 > ratios > PB
0.2611080249434959
Quarters > 0 > ratios > ROE
-12.597917744556092
Quarters > 0 > ratios > ROA
-8.226006246999484
Quarters > 0 > ratios > FCF
-10210000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
317000
Quarters > 1 > income Statement > gross Profit
-317000
Quarters > 1 > income Statement > operating Expenses
16744000
Quarters > 1 > income Statement > operating Income
-17061000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-15675000
Quarters > 1 > income Statement > net Income
-15675000
Quarters > 1 > income Statement > eps
-0.701154052603328
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
22356000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-15358000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
1386000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
14697000
Quarters > 1 > balance Sheet > short Term Investments
112451000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
129690000
Quarters > 1 > balance Sheet > property Plant Equipment
49159000
Quarters > 1 > balance Sheet > total Assets
179453000
Quarters > 1 > balance Sheet > payables
2294000
Quarters > 1 > balance Sheet > short Term Debt
1961000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
56762000
Quarters > 1 > balance Sheet > equity
122691000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-15675000
Quarters > 1 > cash Flow > depreciation
317000
Quarters > 1 > cash Flow > change In Working Capital
1711000
Quarters > 1 > cash Flow > cash From Operations
-11829000
Quarters > 1 > cash Flow > capital Expenditures
48000
Quarters > 1 > cash Flow > cash From Investing
11292000
Quarters > 1 > cash Flow > cash From Financing
117000
Quarters > 1 > cash Flow > net Change In Cash
-420000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.701154052603328
Quarters > 1 > ratios > PB
0.23414480279727118
Quarters > 1 > ratios > ROE
-12.77599823947967
Quarters > 1 > ratios > ROA
-8.734877655987919
Quarters > 1 > ratios > FCF
-11877000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
317000
Quarters > 2 > income Statement > gross Profit
-317000
Quarters > 2 > income Statement > operating Expenses
17341000
Quarters > 2 > income Statement > operating Income
-17341000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-15758000
Quarters > 2 > income Statement > net Income
-15758000
Quarters > 2 > income Statement > eps
-0.7066367713004484
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
22300000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-17024000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1583000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
15117000
Quarters > 2 > balance Sheet > short Term Investments
123136000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
140364000
Quarters > 2 > balance Sheet > property Plant Equipment
50268000
Quarters > 2 > balance Sheet > total Assets
191242000
Quarters > 2 > balance Sheet > payables
1366000
Quarters > 2 > balance Sheet > short Term Debt
262000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
54650000
Quarters > 2 > balance Sheet > equity
136592000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-15758000
Quarters > 2 > cash Flow > depreciation
317000
Quarters > 2 > cash Flow > change In Working Capital
-927000
Quarters > 2 > cash Flow > cash From Operations
-14530000
Quarters > 2 > cash Flow > capital Expenditures
59000
Quarters > 2 > cash Flow > cash From Investing
3060000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-11470000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.7066367713004484
Quarters > 2 > ratios > PB
0.20978900667681855
Quarters > 2 > ratios > ROE
-11.536546796298465
Quarters > 2 > ratios > ROA
-8.239821796467304
Quarters > 2 > ratios > FCF
-14589000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1056000
Quarters > 3 > income Statement > cost Of Revenue
296000
Quarters > 3 > income Statement > gross Profit
528000
Quarters > 3 > income Statement > operating Expenses
18278000
Quarters > 3 > income Statement > operating Income
-18278000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-16448000
Quarters > 3 > income Statement > net Income
-16448000
Quarters > 3 > income Statement > eps
-0.9684408855393312
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
16984000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-17982000
Quarters > 3 > income Statement > operating Margin
-1730.871212121212
Quarters > 3 > income Statement > total Other Income Expense Net
1830000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
26587000
Quarters > 3 > balance Sheet > short Term Investments
125527000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
154390000
Quarters > 3 > balance Sheet > property Plant Equipment
51360000
Quarters > 3 > balance Sheet > total Assets
206409000
Quarters > 3 > balance Sheet > payables
1274000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
55767000
Quarters > 3 > balance Sheet > equity
150642000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-16448000
Quarters > 3 > cash Flow > depreciation
296000
Quarters > 3 > cash Flow > change In Working Capital
-1126000
Quarters > 3 > cash Flow > cash From Operations
-15563000
Quarters > 3 > cash Flow > capital Expenditures
466000
Quarters > 3 > cash Flow > cash From Investing
1823000
Quarters > 3 > cash Flow > cash From Financing
113000
Quarters > 3 > cash Flow > net Change In Cash
-13627000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.9684408855393312
Quarters > 3 > ratios > PB
0.14487619654545214
Quarters > 3 > ratios > ROE
-10.918601717980378
Quarters > 3 > ratios > ROA
-7.968644778086227
Quarters > 3 > ratios > FCF
-16029000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-15.178977272727273
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1086000
Annuals > 0 > income Statement > gross Profit
-1086000
Annuals > 0 > income Statement > operating Expenses
72181000
Annuals > 0 > income Statement > operating Income
-73267000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-65363000
Annuals > 0 > income Statement > net Income
-65363000
Annuals > 0 > income Statement > eps
-3.8485044747998116
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
16984000
Annuals > 0 > income Statement > income Tax Expense
-65363000
Annuals > 0 > income Statement > EBITDA
-64277000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
7904000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
26587000
Annuals > 0 > balance Sheet > short Term Investments
125527000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
154390000
Annuals > 0 > balance Sheet > property Plant Equipment
51360000
Annuals > 0 > balance Sheet > total Assets
206409000
Annuals > 0 > balance Sheet > payables
1274000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
55767000
Annuals > 0 > balance Sheet > equity
150642000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-65363000
Annuals > 0 > cash Flow > depreciation
1086000
Annuals > 0 > cash Flow > change In Working Capital
-1678000
Annuals > 0 > cash Flow > cash From Operations
-60841000
Annuals > 0 > cash Flow > capital Expenditures
2536000
Annuals > 0 > cash Flow > cash From Investing
-26101000
Annuals > 0 > cash Flow > cash From Financing
89823000
Annuals > 0 > cash Flow > net Change In Cash
2881000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-3.8485044747998116
Annuals > 0 > ratios > PB
0.14487619654545214
Annuals > 0 > ratios > ROE
-43.38962573518673
Annuals > 0 > ratios > ROA
-31.666739337916468
Annuals > 0 > ratios > FCF
-63377000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
957000
Annuals > 1 > income Statement > gross Profit
-957000
Annuals > 1 > income Statement > operating Expenses
54796000
Annuals > 1 > income Statement > operating Income
-54796000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-49434000
Annuals > 1 > income Statement > net Income
-49434000
Annuals > 1 > income Statement > eps
-2.22281846312567
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
22239333
Annuals > 1 > income Statement > income Tax Expense
-5282000
Annuals > 1 > income Statement > EBITDA
-53839000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
5362000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
23706000
Annuals > 1 > balance Sheet > short Term Investments
97046000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
124204000
Annuals > 1 > balance Sheet > property Plant Equipment
4575000
Annuals > 1 > balance Sheet > total Assets
129894000
Annuals > 1 > balance Sheet > payables
2222000
Annuals > 1 > balance Sheet > short Term Debt
2195000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
256976000
Annuals > 1 > balance Sheet > equity
-127082000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-49434000
Annuals > 1 > cash Flow > depreciation
957000
Annuals > 1 > cash Flow > change In Working Capital
-799000
Annuals > 1 > cash Flow > cash From Operations
-46855000
Annuals > 1 > cash Flow > capital Expenditures
633000
Annuals > 1 > cash Flow > cash From Investing
-38260000
Annuals > 1 > cash Flow > cash From Financing
97897000
Annuals > 1 > cash Flow > net Change In Cash
12782000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.22281846312567
Annuals > 1 > ratios > PB
-0.2248748281031145
Annuals > 1 > ratios > ROE
38.89929336963535
Annuals > 1 > ratios > ROA
-38.057185089380575
Annuals > 1 > ratios > FCF
-47488000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
942000
Annuals > 2 > income Statement > gross Profit
-942000
Annuals > 2 > income Statement > operating Expenses
46469000
Annuals > 2 > income Statement > operating Income
-46469000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-45901000
Annuals > 2 > income Statement > net Income
-45901000
Annuals > 2 > income Statement > eps
-2.063955785004883
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
22239333
Annuals > 2 > income Statement > income Tax Expense
-668000
Annuals > 2 > income Statement > EBITDA
-45527000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
568000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
10951000
Annuals > 2 > balance Sheet > short Term Investments
55766000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
68037000
Annuals > 2 > balance Sheet > property Plant Equipment
7726000
Annuals > 2 > balance Sheet > total Assets
76829000
Annuals > 2 > balance Sheet > payables
1402000
Annuals > 2 > balance Sheet > short Term Debt
2338000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
158525000
Annuals > 2 > balance Sheet > equity
-81696000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-45901000
Annuals > 2 > cash Flow > depreciation
942000
Annuals > 2 > cash Flow > change In Working Capital
866000
Annuals > 2 > cash Flow > cash From Operations
-39596000
Annuals > 2 > cash Flow > capital Expenditures
1066000
Annuals > 2 > cash Flow > cash From Investing
16132000
Annuals > 2 > cash Flow > cash From Financing
126000
Annuals > 2 > cash Flow > net Change In Cash
-23338000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-2.063955785004883
Annuals > 2 > ratios > PB
-0.34980345310663924
Annuals > 2 > ratios > ROE
56.18512534273405
Annuals > 2 > ratios > ROA
-59.74436736128285
Annuals > 2 > ratios > FCF
-40662000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
682000
Annuals > 3 > income Statement > gross Profit
-682000
Annuals > 3 > income Statement > operating Expenses
25301000
Annuals > 3 > income Statement > operating Income
-25301000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-25210000
Annuals > 3 > income Statement > net Income
-25210000
Annuals > 3 > income Statement > eps
-1.1335771625884643
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
22239333
Annuals > 3 > income Statement > income Tax Expense
-96000
Annuals > 3 > income Statement > EBITDA
-24619000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
91000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
34289000
Annuals > 3 > balance Sheet > short Term Investments
38744000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
74570000
Annuals > 3 > balance Sheet > property Plant Equipment
3095000
Annuals > 3 > balance Sheet > total Assets
113719000
Annuals > 3 > balance Sheet > payables
1075000
Annuals > 3 > balance Sheet > short Term Debt
377000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
151908000
Annuals > 3 > balance Sheet > equity
-38189000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-25210000
Annuals > 3 > cash Flow > depreciation
682000
Annuals > 3 > cash Flow > change In Working Capital
-837000
Annuals > 3 > cash Flow > cash From Operations
-23248000
Annuals > 3 > cash Flow > capital Expenditures
2034000
Annuals > 3 > cash Flow > cash From Investing
-59285000
Annuals > 3 > cash Flow > cash From Financing
105526000
Annuals > 3 > cash Flow > net Change In Cash
22993000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.1335771625884643
Annuals > 3 > ratios > PB
-0.7483187018513184
Annuals > 3 > ratios > ROE
66.01377359972767
Annuals > 3 > ratios > ROA
-22.16867893667725
Annuals > 3 > ratios > FCF
-25282000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.6199857053515591
Valuation > metrics > PB
0.2611080249434959
Valuation > final Score
70
Valuation > verdict
73.9% Undervalued
Profitability > metrics > ROE
-12.597917744556092
Profitability > metrics > ROA
-11.550817270881188
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5314743711933484
Risk > metrics > Interest Coverage
-48.86451612903226
Risk > final Score
-147
Risk > verdict
High
Liquidity > metrics > Current Ratio
28.69054441260745
Liquidity > metrics > Quick Ratio
28.69054441260745
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-155
Prev Risks > 1
5
Prev Risks > 2
12
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:30:54.040Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-05
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.62
Earnings History > 0 > eps Estimate
-1.09
Earnings History > 0 > eps Difference
0.47
Earnings History > 0 > surprise Percent
43.1193
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-05
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.7
Earnings History > 1 > eps Estimate
-1.02
Earnings History > 1 > eps Difference
0.32
Earnings History > 1 > surprise Percent
31.3725
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-09
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.71
Earnings History > 2 > eps Estimate
-1.02
Earnings History > 2 > eps Difference
1.73
Earnings History > 2 > surprise Percent
169.6078
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-27
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.74
Earnings History > 3 > eps Estimate
-0.84
Earnings History > 3 > eps Difference
0.1
Earnings History > 3 > surprise Percent
11.9048
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-08
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.74
Earnings History > 4 > eps Estimate
-0.73
Earnings History > 4 > eps Difference
-0.01
Earnings History > 4 > surprise Percent
-1.3699
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-12
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.77
Earnings History > 5 > eps Estimate
-0.65
Earnings History > 5 > eps Difference
-0.12
Earnings History > 5 > surprise Percent
-18.4615
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-13
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-12.27
Earnings History > 6 > eps Estimate
-0.55
Earnings History > 6 > eps Difference
-11.72
Earnings History > 6 > surprise Percent
-2130.9091
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-9.76
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-9.76
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-09-30
Earnings History > 8 > report Date
2019-11-07
Earnings History > 8 > date
2019-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1
Earnings History > 8 > eps Estimate
-1.07
Earnings History > 8 > eps Difference
0.07
Earnings History > 8 > surprise Percent
6.5421
Earnings History > 9 > period
2019-06-30
Earnings History > 9 > report Date
2019-08-06
Earnings History > 9 > date
2019-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.01
Earnings History > 9 > eps Estimate
-1.04
Earnings History > 9 > eps Difference
0.03
Earnings History > 9 > surprise Percent
2.8846
Earnings History > 10 > period
2019-03-31
Earnings History > 10 > report Date
2019-05-07
Earnings History > 10 > date
2019-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-1.13
Earnings History > 10 > eps Estimate
-0.89
Earnings History > 10 > eps Difference
-0.24
Earnings History > 10 > surprise Percent
-26.9663
Earnings History > 11 > period
2018-12-31
Earnings History > 11 > report Date
2019-02-27
Earnings History > 11 > date
2018-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.84
Earnings History > 11 > eps Estimate
-0.91
Earnings History > 11 > eps Difference
0.07
Earnings History > 11 > surprise Percent
7.6923
Earnings History > 12 > period
2018-09-30
Earnings History > 12 > report Date
2018-11-06
Earnings History > 12 > date
2018-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.97
Earnings History > 12 > eps Estimate
-0.88
Earnings History > 12 > eps Difference
-0.09
Earnings History > 12 > surprise Percent
-10.2273
Earnings History > 13 > period
2018-06-30
Earnings History > 13 > report Date
2018-08-07
Earnings History > 13 > date
2018-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.85
Earnings History > 13 > eps Estimate
-0.78
Earnings History > 13 > eps Difference
-0.07
Earnings History > 13 > surprise Percent
-8.9744
Earnings History > 14 > period
2018-03-31
Earnings History > 14 > report Date
2018-05-09
Earnings History > 14 > date
2018-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.74
Earnings History > 14 > eps Estimate
-0.8
Earnings History > 14 > eps Difference
0.06
Earnings History > 14 > surprise Percent
7.5
Earnings History > 15 > period
2017-12-31
Earnings History > 15 > report Date
2018-03-08
Earnings History > 15 > date
2017-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.82
Earnings History > 15 > eps Estimate
-0.9
Earnings History > 15 > eps Difference
0.08
Earnings History > 15 > surprise Percent
8.8889
Earnings History > 16 > period
2017-09-30
Earnings History > 16 > report Date
2017-11-14
Earnings History > 16 > date
2017-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.88
Earnings History > 16 > eps Estimate
-0.89
Earnings History > 16 > eps Difference
0.01
Earnings History > 16 > surprise Percent
1.1236
Earnings History > 17 > period
2017-06-30
Earnings History > 17 > report Date
2017-08-10
Earnings History > 17 > date
2017-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.87
Earnings History > 17 > eps Estimate
-0.79
Earnings History > 17 > eps Difference
-0.08
Earnings History > 17 > surprise Percent
-10.1266
Earnings History > 18 > period
2017-03-31
Earnings History > 18 > report Date
2017-05-11
Earnings History > 18 > date
2017-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.83
Earnings History > 18 > eps Estimate
-0.92
Earnings History > 18 > eps Difference
0.09
Earnings History > 18 > surprise Percent
9.7826
Earnings History > 19 > period
2016-12-31
Earnings History > 19 > report Date
2017-03-09
Earnings History > 19 > date
2016-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.91
Earnings History > 19 > eps Estimate
-0.75
Earnings History > 19 > eps Difference
-0.16
Earnings History > 19 > surprise Percent
-21.3333
Earnings History > 20 > period
2016-09-30
Earnings History > 20 > report Date
2016-11-10
Earnings History > 20 > date
2016-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.94
Earnings History > 20 > eps Estimate
-0.65
Earnings History > 20 > eps Difference
-0.29
Earnings History > 20 > surprise Percent
-44.6154
Earnings History > 21 > period
2016-06-30
Earnings History > 21 > report Date
2016-08-31
Earnings History > 21 > date
2016-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-6.43
Earnings History > 21 > eps Estimate
-1.33
Earnings History > 21 > eps Difference
-5.1
Earnings History > 21 > surprise Percent
-383.4586
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA). The company's lead product candidate is BBI-355, an ecDNA-directed therapeutic candidate and oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. It also develops BBI-098, a picomolar biochemical inhibition of checkpoint kinase 1 demonstrating central nervous system penetrance in preclinical models. In addition, the company offers ECHO, an ecDNA harboring oncogenes diagnostic test to detect ecDNA in patient tumor specimens; and Spyglass platform, a platform used to identify druggable targets in oncogene amplified cancers. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADividend Watch: Will Bold Eagle Acquisition Corp Equity Right announce a stock split - July 2025 Fed Impact & High Return Stock Watch Alerts baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$3
Analyst Picks
Strong Buy
0
Buy
1
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Boundless Bio, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.62
EPS Estimate
-1.09
EPS Difference
0.47
Surprise Percent
43.1193%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.